194 related articles for article (PubMed ID: 30105542)
21. Novel lipid-coated mesoporous silica nanoparticles loaded with thymoquinone formulation to increase its bioavailability in the brain and organs of Wistar rats.
Fahmy HM; Ahmed MM; Mohamed AS; Shams-Eldin E; Abd El-Daim TM; El-Feky AS; Mustafa AB; Abd Alrahman MW; Mohammed FF; Fathy MM
BMC Pharmacol Toxicol; 2022 Sep; 23(1):71. PubMed ID: 36163187
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of immunopotentiation using tetanus toxoid-based nanoparticulate dissolvable microneedles.
Waghchaure M; Govardhane S; Shende P
Biomed Microdevices; 2021 Jun; 23(3):32. PubMed ID: 34181103
[TBL] [Abstract][Full Text] [Related]
23. A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery.
McNeela EA; O'Connor D; Jabbal-Gill I; Illum L; Davis SS; Pizza M; Peppoloni S; Rappuoli R; Mills KH
Vaccine; 2000 Dec; 19(9-10):1188-98. PubMed ID: 11137256
[TBL] [Abstract][Full Text] [Related]
24. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
Zhang K; Zhou D; Wang Z; Zhang Y; He P
Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
[TBL] [Abstract][Full Text] [Related]
25. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
[TBL] [Abstract][Full Text] [Related]
26. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
Li Z; Zhang Y; Zhang K; Wu Z; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
[TBL] [Abstract][Full Text] [Related]
28. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
[TBL] [Abstract][Full Text] [Related]
29. Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs.
Amidi M; Pellikaan HC; Hirschberg H; de Boer AH; Crommelin DJ; Hennink WE; Kersten G; Jiskoot W
Vaccine; 2007 Sep; 25(37-38):6818-29. PubMed ID: 17692440
[TBL] [Abstract][Full Text] [Related]
30. Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine.
Lee JY; Kim MK; Nguyen TL; Kim J
ACS Appl Mater Interfaces; 2020 Aug; 12(31):34658-34666. PubMed ID: 32662625
[TBL] [Abstract][Full Text] [Related]
31. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
Verheul RJ; Slütter B; Bal SM; Bouwstra JA; Jiskoot W; Hennink WE
J Control Release; 2011 Nov; 156(1):46-52. PubMed ID: 21784113
[TBL] [Abstract][Full Text] [Related]
32. Poly-l-lactic acid scaffold incorporated chitosan-coated mesoporous silica nanoparticles as pH-sensitive composite for enhanced osteogenic differentiation of human adipose tissue stem cells by dexamethasone delivery.
Porgham Daryasari M; Dusti Telgerd M; Hossein Karami M; Zandi-Karimi A; Akbarijavar H; Khoobi M; Seyedjafari E; Birhanu G; Khosravian P; SadatMahdavi F
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4020-4029. PubMed ID: 31595797
[TBL] [Abstract][Full Text] [Related]
33. Alginate coated chitosan microparticles mediated oral delivery of diphtheria toxoid. Part A. Systematic optimization, development and characterization.
Shukla A; Mishra V; Bhoop BS; Katare OP
Int J Pharm; 2015 Nov; 495(1):220-233. PubMed ID: 26319633
[TBL] [Abstract][Full Text] [Related]
34. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
35. Encapsulation of antigen-loaded silica nanoparticles into microparticles for intradermal powder injection.
Deng Y; Mathaes R; Winter G; Engert J
Eur J Pharm Sci; 2014 Oct; 63():154-66. PubMed ID: 25042055
[TBL] [Abstract][Full Text] [Related]
36. Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy.
Lohiya G; Katti DS
Carbohydr Polym; 2022 Feb; 277():118822. PubMed ID: 34893239
[TBL] [Abstract][Full Text] [Related]
37. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
Kim YC; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2013 Dec; 172(2):579-88. PubMed ID: 23643528
[TBL] [Abstract][Full Text] [Related]
38. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
39. Co-Delivery of Gemcitabine and Honokiol by Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhances Pancreatic Cancer Therapy via Targeting Depletion of Tumor Stroma.
Liu D; Wang L; Li H; Li D; Zhou J; Wang J; Zhang Q; Cai D
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338418
[TBL] [Abstract][Full Text] [Related]
40. Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles.
Kumar A; Wonganan P; Sandoval MA; Li X; Zhu S; Cui Z
J Control Release; 2012 Oct; 163(2):230-9. PubMed ID: 22921518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
